Home › Acute Kidney Injury › NCT05906758
Ultra-Low Contrast Angiography in AKI
RecruitingPhase 3
Randomized Controlled Trial of Ultra-Low Contrast Coronary Angiography During Acute Kidney Injury (AKI)
Who can join
Ages 18 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: * Hospitalized patients who have AKI at admission or who develop AKI during admission and require invasive coronary angiography will be included in the trial. Exclusion Criteria: * Stabilized renal function manifested by unchanged or downtrending serum creatinine during a 24-hour period prior to enrollment. * Contraindication for invasive coronary angiography other than AKI. * Percutaneous coronary intervention is indicated and cannot be postponed by 7 days. * Need for renal replacement therapy before coronary angiography or planned renal replacement therapy after coronary angiography (if premeditated before coronary angiography). * Administration of intravascular contrast media during 7 days prior to the coronary angiography or within 6 days after coronary angiography. * Pregnant patients, prisoners, cognitively impaired subjects, age below 18 years, unable or unwilling to provide informed consent.
About the study
The aim of this study is to evaluate the safety of ultra-low contrast coronary angiography in patients with pre-existing acute kidney injury.
What is being tested
- Angiography (procedure)
Sponsor: Tulane University · Participants: 32 · Started: Sep 5, 2025
Contact the study team
- Zach Rozenbaum, MD · Phone: 504-988-5493
Official record on ClinicalTrials.gov — NCT05906758
Locations in the U.S.
| Louisiana | Tulane University Medical Center, New Orleans University Medical Center, New Orleans |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.